We're delighted to announce that the Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research...

Earlier this year, our Head of Research Dr Nicola McCarthy sat down with Megan Thomas, Multimedia Editor at Drug Discovery World, to explore...

Last week, we were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together. On...

We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited...

We are delighted to share that our Director, Professor Sir Tony Kouzarides – a Professor of Cancer Biology at the University of Cambridge and a...

We are delighted to announce that Chun Hao Wong has joined the Milner team as the MTI lead for the new MRC-AstraZeneca-University of Cambridge...

This year the Milner Institute was delighted to take part in the University of Cambridge’s interdisciplinary Cambridge Festival. The Festival takes...

The functional genomics screening laboratory (FGSL), a joint venture between our Institute at the University of Cambridge, the Medical Research...

We are delighted that our Head of Computational Biology and AI, Dr Namshik Han, was featured on Cytiva’s ‘Discovery Matters' podcast series last...

We are delighted to announce a new partnership with AstraZeneca and the Medical Research Council (MRC) that will establish a new state-of-the-art...

We are delighted to share that the Pathania Lab join a team of researchers who have been awarded £1.5 million in The Brain Tumour Charity's Quest...

We are excited to announce that two new pharma partners — Takeda and Sanofi — have joined the Milner Consortium in the past month. Now with 14...

We are delighted to welcome Dr Cathy Tralau-Stewart as the new Executive Director at the Milner Therapeutics Institute. Cathy will work alongside...

We are delighted to welcome Dr Erica Bello as the new Head of Target Discovery at the Milner Therapeutics Institute. Erica brings to the team broad...

The AI Club for Biomedicine, launched earlier this month, is a new initiative created to bring together the biomedical AI and machine learning...

We are delighted to announce a new collaboration with the NC3Rs this month, which has been established to help NC3Rs-funded researchers translate...

Congratulations to Milner affiliated company STORM Therapeutics, who have announced the start of phase I clinical trials with their first-in-class...

This month we are excited to announce that MSD has joined the Milner Therapeutics Consortium as our 12th pharma partner. This coincides with the...

In May 2021, the Milner Institute launched a rapid response data analysis call, led by Dr Rebecca Harris and Dr Namshik Han. The call sought...

We are delighted to announce that Alexandra Huener has joined the Milner team as the Head of Entrepreneurship. This exciting new role has been...

The Milner team enjoyed an institute visit with a difference last week, as we welcomed a group of children for Inflammatory Bowel Disease (IBD)...

Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert...

CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to...

The CEO Today Business Women of the Year Awards 2022 edition has been published this week, and we're delighted that Milner Deputy Director Kathryn...

We are thrilled to announce that the Milner collaboration with the medical research charity LifeArc has been expanded into a 5-year strategic...

We are delighted to announce that, with the renewal of the CRUK Cambridge Centre this year, the Milner will become an Affiliated Institute,...

We are excited to announce that the University of Cambridge has launched the Connect: Health Tech microsite and online community platform, as part...

Last month, the Onco-Innovation Programme — part of the CRUK Cambridge Centre and managed by our own Dr Rebecca Harris — launched a new rapid...